Cerus Corp.

United States: Cerus Corp. Reports Operating Results (10-Q).(Financial report)
TendersInfo; 11/9/2009; 931 words; Byline: kusumv03 Cerus Corp. (CERS) filed Quarterly Report for the period ended 2009-09-30. Cerus Corporation is developing medical products...outcomes of stem cell transplantation. Cerus Corp. has a market cap of $72.7 million...

Appointments And Advancements.
BIOWORLD Today; 11/4/2009; 882 words; ...president of technical operations and chief technical officer and Paul Chaplin general manager of its German subsidiary. Cerus Corp., of Concord, Calif., added Timothy Anderson to its board. ISTA Pharmaceuticals Inc., of Irvine, Calif., added...

Other News To Note.
BIOWORLD Today; 11/4/2009; 1878 words; ...topical lidocaine patch from EpiCept Corp., of Englewood Cliffs, N.J...shares being delisted, it said. o Cerus Corp., of Concord, Calif., said it...transfusion-transmitted diseases. Cerus is developing Intercept for use with...

Vitex Offering Brings In $14.4M For Blood Purifying Technology.
BIOWORLD Today; 11/4/2009; 1012 words; ...is the same pricing as East Hills, N.Y.-based Pall Corp.'s $4 million Phase III milestone commitment. Pall...A Vitex competitor in the blood-purifying arena is Cerus Corp., of Concord, Calif., which Parker said has "a very...

Patent No. 7,611,831 Issued on Nov. 3, Assigned to Cerus for Adsorbing Pathogen Inactivation Compound (California Inventor)
US Fed News Service, Including US State News; 11/4/2009; 454 words; ...in a matrix. The inventor was issued U.S. Patent No. 7,611,831 on Nov. 3. The patent has been assigned to Cerus Corp., Concord, Calif. According to the abstract released by the U.S. Patent & Trademark Office: "Methods and...